I would wager to bet that investor loyalty to the

I would wager to bet that investor loyalty to the underdog us present. Cytodyn being the underdog and our loyalty has been built up by the constant attacks that we have experienced from every angle.

One where we know we have a drug that works but isn’t getting it due recognition because of the constant shorting and slamming.

It’s pretty controversial to the average person researching Leronlimab to even use it as a EIND. There is so much bad articles written and so much bs to wade through. It is amazing people are even trying Leronlimab as a EIND. You and I and all the investors know what we know about the history and the science but the average person is being spooked away from Leronlimab if they do the research and that’s a damn shame.

The underdog in this system we have... has found a new path internationally and they took the right path at the right time to find their way to use and saving lives. We will achieve substantial revenue because we know Leronlimab saves lives. We can build our war chest to buy the influence we need to purchase to get our way with our own FDA if that is what it takes and it sure seems that way.

The story of Cytodyn is nothing short of a block buster movie or best selling book and I can’t wait for the underdog story to come to light. I would love to see the inside story of this little company. We see from the outside and I like what I see of our management and their transparency. It serves the underdog story well and allows us all the loyalty to fight for this little molecule.

Of coarse this is just my opinion... but I am as loyal as a dog and I tend to bite when provoked.